Prognostic and immune correlation of IDO1 promoter methylation in breast cancer

Prognostic and immune correlation of IDO1 promoter methylation in breast cancer

Abstract Indoleamine 2,3-dioxygenase 1 (IDO1) plays an important role in the initiation and progression of breast cancer. DNA promoter methylation status has the potential to be used as a biomarker for predicting the response to immunotherapy. This study aimed to investigate the biological and clini...

Full description

Saved in:
Bibliographic Details
Main Authors: Shirong Ding, Ruozhu Yang, Jiahao Meng, Xinyu Guan, Yue Hong, Jiachi Xu, Limeng Qu, Jingfen Ji, Wenjun Yi, Qiongyan Zou, Qian Long
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
DNA methylation
Epigenetics
Biomarker
IDO1
Breast cancer
Tumor immune microenvironment
Online Access:https://doi.org/10.1038/s41598-024-79149-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-79149-w

Similar Items